Potter M A, Luxton G
Department of Medical Biochemistry, McMaster University, Hamilton, Ont.
Clin Invest Med. 1999 Apr;22(2):44-52.
To examine the effectiveness of prealbumin measurement as a routine diagnostic test for protein calorie malnutrition (PCM) in emergency admissions.
Cohort study.
Canadian tertiary care hospital.
A total of 147 consecutive patients admitted through the emergency department, excluding psychiatric admissions, for whom a serum sample was sent to the chemistry laboratory.
(1) Albumin and prealbumin levels to diagnose PCM; (2) length of stay (LOS), in-hospital mortality, and nutritional supplementation in patients with PCM; and (3) cost analysis of using prealbumin level as an admission screening test for PCM.
Twenty-four per cent of the patients had at least mild PCM (prealbumin level < 160 mg/L). Albumin level (< 35 g/L) had a sensitivity of 50% and specificity of 95% in identifying PCM. The mean LOS in the patients with PCM was 16 (standard deviation 18) days, compared with 8 (SD 12) days in the patients without PCM (p < 0.0002). The in-hospital mortality rate was 17% in patients with PCM compared with 4% in patients without PCM (p < 0.02). Only 42% of patients with PCM received nutritional supplementation. Cost analysis of screening with prealbumin level projected a saving of $414 per patient screened.
PCM is underdiagnosed in current clinical practice and is associated with an increased LOS and mortality rate. Prealbumin is a biochemical marker that could be used as a cost-effective screening test to identify patients with PCM who may benefit from nutritional supplementation.
探讨血清前白蛋白检测作为急诊入院患者蛋白质 - 热量营养不良(PCM)常规诊断试验的有效性。
队列研究。
加拿大三级护理医院。
共有147例通过急诊科连续入院的患者,不包括精神科入院患者,均已将血清样本送至化学实验室。
(1)白蛋白和前白蛋白水平用于诊断PCM;(2)PCM患者的住院时间(LOS)、院内死亡率和营养补充情况;(3)使用前白蛋白水平作为PCM入院筛查试验的成本分析。
24%的患者至少存在轻度PCM(前白蛋白水平<160 mg/L)。白蛋白水平(<35 g/L)在识别PCM时的敏感性为50%,特异性为95%。PCM患者的平均住院时间为16(标准差18)天,而无PCM患者为8(标准差12)天(p<0.0002)。PCM患者的院内死亡率为17%,无PCM患者为4%(p<0.02)。只有42%的PCM患者接受了营养补充。用前白蛋白水平进行筛查的成本分析显示,每位接受筛查的患者可节省414美元。
在目前的临床实践中,PCM诊断不足,且与住院时间延长和死亡率增加相关。前白蛋白是一种生化标志物,可作为一种经济有效的筛查试验,用于识别可能从营养补充中获益的PCM患者。